Mach7 Technologies Ltd. · ASX:M7T
Mach7 Technologies — Wilsons Drug and Device Conference 2023
9 slides from Mach7 Technologies's conference presentation, Oct 26, 2023
Slide 1: ASX Announcement: Wilsons Drug and Device Conference Presentation
ASX Announcement 26 October 2023 Wilsons Drug and Device Conference Presentation Mach7 Technologies Limited (“M7T” or “the Company”) (ASX:M7T), a company specialising in innovative imaging software solutions, today provides a copy of a presentation that will be delivered by the CEO Mike Lampron at t
Slide 2: Wilsons Drug and Device Conference Presentation
For personal use only Wilsons Drug and Device Conference Presentation Enterprise Imaging Session October 2023 Mach7 Technologies ASX: M7T 1
Slide 3: Mach7 – Independence through innovation
For personal use only Mach7 – Independence through innovation Mach7 Technologies develops innovative image management and viewing solutions that form the core of an integrated enterprise imaging ecosystem. Enterprise Imaging refers to a set of strategies, initiatives and workflows implemented across
Slide 4: Medical Imaging Landscape
For personal use only Medical Imaging Landscape Fragmentation Complexity Investment Technology • Fragmented imaging • More complex reading • Global imaging IT Imaging IT providers must market with long-time environments and remote investment returned support health systems in legacy vendors losing w
Slide 5: Market dynamics influencing Enterprise Imaging adoption
Market dynamics influencing Enterprise Imaging adoption Factors driving demand • Decisions increasingly driven by C-suite with emphasis on enterprise efficiency, simplified procurement and For personal use only cost savings. • Growing investment across non-acute providers. Many imaging centres and a
Slide 6: Competitive Environment
Competitive Environment Key Competitors and Market Share For personal use only Growth across all markets is forecast to peak short-term (2023- 2024), driven by the dovetail of the radiology replacement cycle, continued prioritisation of operational workflow tools and increased opportunities to upsel
Slide 7: Our Differentiators
Our Differentiators • Enterprise First Strategy • ‘Top Performer’ Product Rankings For personal use only • VNA backend data management solution • Mach7’s Viewer ranked #2 by independent designed and built for entire healthcare customer survey (KLAS Research). Features network rather than the radiolo
Slide 8: Our Scalable Future Proof Framework
For personal use only Our Scalable Future Proof Framework Build on Existing Innovative Long-Term Allow Anyone to Join Work Technologies Scalability Builds upon the Provides a point of access Allows new and innovative Ensures variation around a substantial work done in to allow all types of technolog
Slide 9: Disclaimer “forward looking” statements
Disclaimer “forward looking” statements Summary of information: This presentation contains general and background information about Mach7 Risks: An investment in M7T securities is subject to investment and other known and unknown risks, Technologies Limited (“M7T”) activities current as at the date
Mach7 Technologies — Wilsons Drug and Device Conference 2023 on 6ix